Drug Approval | October 14, 2021
IOL receives Korean FDA approval
The company’s pharmaceutical API products Ibuprofen and fenofibrate got the go-ahead
The company’s pharmaceutical API products Ibuprofen and fenofibrate got the go-ahead
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
In collaboration with RAND Europe, the Vitality calculator predicts an individual's healthspan and future health risks
It is one of the first companies to launch a bioequivalent version of the dry powder inhaler and it's part of the company’s strategic exclusive in-licensing arrangement to market Tiotropium DPI in Western Europe and the UK
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
The applicants will only have to get their Good Manufacturing Practices certification validated every five years to retain their licence
The company plans to expand its portfolio in regulated markets aggressively
Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021
The transaction is anticipated to close in the first quarter of 2022
A total of 8308 stores are open across India and medicines are priced at affordable rates
Subscribe To Our Newsletter & Stay Updated
